Recurrent Glioblastoma Multiforme
Oncology·MeSH: Glioblastoma
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| azd1390 | ASTRAZENECA PLC (AZN) |
Frequently asked questions
How many drugs are in development for Recurrent Glioblastoma Multiforme?
BioSniper tracks 1 drug in development for Recurrent Glioblastoma Multiforme across 1 company.
How many clinical trials target Recurrent Glioblastoma Multiforme?
There are 1 clinical trial targeting Recurrent Glioblastoma Multiforme tracked by BioSniper.
Analyze ASTRAZENECA PLC's Recurrent Glioblastoma Multiforme pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company